Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research. What are the most promising ...

Methotrexate (MTX) is a drug that has been used to treat psoriatic arthritis (PsA) for more than 40 years. Alone or in combination with other therapies, MTX is considered a first-line treatment ...

Biologics targeting IL-12, IL-23, or IL-17 are linked to lower infection risk in older adults with psoriatic disease compared to other systemic treatments. The study utilized Ontario's health ...